Janssen files suit in U.S. to block sale of Samsung Bioepis’ Remicade copy | Reuters

http://ift.tt/2pZ81ae

200) && (this.width >= this.height) ? 200: true); max-height: 200px; height: expression((this.height > 200) && (this.height >= this.width) ? 200: true); border: none;’/>
A unit of healthcare conglomerate Johnson & Johnson filed a lawsuit to block a copy of its rheumatoid arthritis drug Remicade made by South Korea’s Samsung Bioepis Co Ltd from being sold in the United States.

posted by friends:
 (3)
@DrHubaEvaluator on Twitter
@DrHubaEvaluator: REUTERS: Janssen files suit in U.S. to block sale of Samsung Bioepis’ Remicade copy ow.ly/1h3550bAFu6

@ReutersBiz on Twitter
@ReutersBiz: Janssen files suit in U.S. to block sale of Samsung Bioepis’ Remicade copy reut.rs/2pZsyvf

@josephjett on Twitter
@josephjett: Janssen files suit in U.S. to block sale of Samsung Bioepis’ Remicade copy http://ift.tt/2qydfws; http://pic.twitter.com/ISPEGwhe78

posted by followers of the list:
 (0)

Vía All News on ‘The Twitter Times: Muzaffar69/corpgov’ http://ift.tt/2qZ9qlp

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: